.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
US Army
US Department of Justice
Argus Health
Julphar
Harvard Business School
Teva
Deloitte
Citi
Boehringer Ingelheim

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,670,637

« Back to Dashboard

Details for Patent: 5,670,637

Title: Nucleic acid ligands
Abstract:A new class of nucleic acid compounds, referred to as nucleic acid antibodies, have been shown to exist that have a specific binding affinity for three dimensional molecular targets. In a preferred embodiment the ligand components of the nucleic acid antibodies are identified by the method of the invention referred to as the Systematic Evolution of Ligands by EXponential enrichment (SELEX), wherein a candidate mixture of nucleic acids are iteratively enriched in high affinity nucleic acids and amplified for further partitioning.
Inventor(s): Gold; Larry (Boulder, CO), Tuerk; Craig (Boulder, CO)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:Mar 27, 1995
Application Number:08/412,110
Claims:1. A non-naturally occurring nucleic acid ligand having a specific binding affinity for a target molecule, said target molecule being a protein, wherein said nucleic acid ligand is not a nucleic acid having the known physiological function of being bound by the target molecule.

2. The nucleic acid ligand of claim 1 wherein said nucleic acid ligand is selected from the group consisting of single-stranded RNA, double-stranded RNA, single-stranded DNA and double-stranded DNA.

3. The nucleic acid ligand of claim 1 wherein said nucleic acid ligand is single-stranded.

4. The nucleic acid ligand of claim 3 wherein said nucleic acid ligand is RNA.

5. The nucleic acid ligand of claim 3 wherein said nucleic acid ligand is DNA.

6. The nucleic acid ligand of claim 1 wherein said nucleic acid ligand is double stranded.

7. The nucleic acid ligand of claim 6 wherein said nucleic acid ligand is RNA.

8. The nucleic acid ligand of claim 6 wherein said nucleic acid ligand is DNA.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Accenture
Mallinckrodt
Argus Health
AstraZeneca
Merck
Moodys
Johnson and Johnson
Covington
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot